| 2221 |
TELESTA TABLETS 80 MG |
TELMISARTAN 80 MG |
TABLETS |
ALU-ALU BLISTER |
TREATMENT OF ESSENTIAL HYPERTENSION AND CARDIOVASCULAR PREVENTION |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 5768/24 |
27-Jun-2024 |
26-Jun-2027 |
View |
| 2222 |
TENOVIR |
TENOFOVIR DISOPROXIL FUMARATE 300 MG |
FILM COATED TABLET |
BOTTLE |
INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV -1 INFECTIONS IN ADULTS AND PEDIATRIC PATIENTS 2 YEARS OF AGE AND OLDER. FOR THE TREATMENT OF CHORNIC HEPATITIS B IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4188/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2223 |
TOB-DEX |
TOBRAMYCIN SULFATE USP EQ.TO TOBRAMYCIN 0.3 % W/V, DEXAMETHASONE SODIUM PHOSPHATE BP 0.1 % W/V |
EYE DROPS |
BOTTLE |
PREVENTION AND TREATMENT OF INFLAMMATION AND PREVENTION OF INFECTION ASSOCIATED WITH CATARACT SURGERY IN ADULTS AND CHILDREN AGED 2 YEARS AND OLDER |
NULL |
POUNSAB PHARMA CO.,LTD |
AUROLAB |
INDIA |
CERTIFICATE RELEASED |
10 I 5612/23 |
09-Oct-2023 |
08-Oct-2026 |
View |
| 2224 |
TPROST |
TRAVOPROST IP 0.004 % W/V |
EYE DROPS |
BOTTLE |
DECREASE OF ELEVATED INTRAOCULAR PRESSURE IN ADULT PATIENTS WITH OCULAR HYPERTENSION OR OPEN-ANGLE GLAUCOMA, DECREASE OF ELEVATED INTRAOCULAR PRESSURE IN PAEDIATRIC PATIENTS AGED 2 MONTHS TO < 18 YEARS WITH OCULAR HYPERTENSION OR PAEDIATRIC GLAUCOMA |
NULL |
POUNSAB PHARMA CO.,LTD |
AUROLAB |
INDIA |
CERTIFICATE RELEASED |
10 I 5613/23 |
09-Oct-2023 |
08-Oct-2026 |
View |
| 2225 |
TRUTIL |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE PELLETS EQ.TO ESOMEPRAZOLE 40 MG |
CAPSULE |
BLISTERPACK |
TO TREAT DUODENAL AND GASTRIC ULERS, EROSIVE ESOPHAGITIS, GASTROESOPHAGEAL REFLUX DISEASE ( GERD) AND THE ZOLLINGER - ELLISON SYNDROME. ESOMEPRAZOLE IS ALSO USED WITH ANTIBIOTICS TO TREAT ULCERS THAT ARE CAUSED BY THE H.PYLORI BACTERIA. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4194/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2226 |
TRUTIL |
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE PELLETS EQ.TO ESOMEPRAZOLE 20 MG |
CAPSULE |
BLISTERPACK |
TO TREAT DUODENAL AND GASTRIC ULERS, EROSIVE ESOPHAGITIS, GASTROESOPHAGEAL REFLUX DISEASE ( GERD) AND THE ZOLLINGER - ELLISON SYNDROME. ESOMEPRAZOLE IS ALSO USED WITH ANTIBIOTICS TO TREAT ULCERS THAT ARE CAUSED BY THE H.PYLORI BACTERIA. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4196/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2227 |
ULCOFIN |
FAMOTIDINE USP 10 MG/ 5ML |
SUSPENSION |
BOTTLE |
FOR THE MANAGEMENT OF ACTIVE DUODENAL ULCER, ACTIVE GASTRIC ULCER, HYPERSECRETORY STATES LIKE ZOLLINGER-ELISSON, SYMPTOMATIC RELIEF GASTRO ESOPHAGEAL REFLUX DISEASE |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
09 I 4186/16 |
02-NOV-2023 |
01-NOV-2026 |
View |
| 2228 |
ULCOFIN 20 MG TABLETS |
FAMOTIDINE 20 MG |
TABLET |
BLISTERPACK |
FOR MANAGEMENT OF ACTIVE DUODENAL ULCER, ACTIVE GASTRIC ULCER, HYPERSECRETORY STATES LIKE ZOLLINGER-ELISSON, SYMPTOMATIC RELIEF OF GASTROESOPHAGEAL REFLUX DISEASE, PROPHYLAXIS OF GASTROINTESTINAL HAEMORRHAGE AS A CONSEQUENCE OF STRESS ULCERATION. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 4461/18 |
23-AUG-2022 |
22-AUG-2025 |
View |
| 2229 |
ULCOFIN 40 MG TABLETS |
FAMOTIDINE 40 MG |
TABLET |
BLISTERPACK |
DUDODENAL ULCER BENIGN, GASTRIC ULCER; HYPERSECRETORY STATES LIKE ZOLLINGER-ELISSON, SYMPTOMATIC RELIEF OF GASTROESOPHAGEAL REFLUX DISEASE, PROPHYLAXIS OF GASTROINTESTNAL HAEMORRHAGE AS A CONSEQUENCE OF STRESS ULCERATION. |
NULL |
POUNSAB PHARMA CO.,LTD |
PHARMIX LABORATORIES (PVT ) LTD |
PAKISTAN |
CERTIFICATE RELEASED |
06 I 4462/18 |
23-AUG-2022 |
22-AUG-2025 |
View |
| 2230 |
XAROBAN TABLETS 10 MG |
RIVAROXABAN 10 MG |
TABLETS
|
ALU-ALU BLISTER |
REDUCTION OF RISK OF STROKE AND SYSTEMIC EMBOLISM IN NONVALVULAR ATRIAL FIBRILLATION, TREATMENT OF DEEP VEIN THROMBOSIS, TREATMENT OF PULMONARY EMBOLISM, REDUCTION IN THE RISK OF RECURRENCE OF DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM, PROPHYLAXIS OF DEEP VEIN THROMBOSIS FOLLOWING HIP OR KNEE REPLACEMENT SURGERY |
NULL |
POUNSAB PHARMA CO.,LTD |
THE SEARLE COMPANY LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
05 I 5512/23 |
09-MAY-2023 |
08-MAY-2026 |
View |
